300981 中紅醫療
按盤價 
18.150 +2.230 (+14.008%)
18.150 +2.230 (+14.008%) | 2026/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 1,478,364 | 19.46% | 2,373,207 | 2,456,651 | 2,105,250 | 1,572,569 | |
| 減：營業總成本 | 1,338,014 | 8.01% | 2,451,907 | 2,368,710 | 2,086,359 | 1,522,755 | |
| 其中:營業成本 | 1,124,092 | 2.81% | 2,108,627 | 2,128,184 | 1,850,526 | 1,420,088 | |
| 財務費用 | 63,556 | -449.19% | 13,469 | (72,061) | (37,591) | (61,285) | |
| 資產減值損失 | (12,196) | -29.19% | (116,153) | (228,888) | (253,885) | (143,686) | |
| 公允價值變動收益 | 30,608 | 50.43% | 42,863 | 48,108 | 60,190 | 51,458 | |
| 投資收益 | 22,989 | 443.50% | 26,579 | 11,020 | 22,759 | 14,238 | |
| 其中：對聯營企業和合營企業的投資收益 | -- | -- | 1,538 | 145 | (320) | -- | |
| 營業利潤 | 181,952 | 3,432.55% | (125,529) | (65,737) | (136,873) | (10,995) | |
| 利潤總額 | 181,849 | 2,850.91% | (124,109) | (66,903) | (137,670) | 51,272 | |
| 減：所得稅費用 | 23,316 | 1,075.11% | (7,632) | 18,927 | (10,003) | (15,711) | |
| 淨利潤 | 158,533 | 3,694.20% | (116,477) | (85,830) | (127,667) | 66,982 | |
| 減：非控股權益 | (108) | -93.07% | (4,094) | 1,298 | 3,204 | 66 | |
| 股東淨利潤 | 158,642 | 2,662.38% | (112,383) | (87,129) | (130,871) | 66,916 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.371 | 2,670.15% | -0.260 | -0.200 | -0.340 | 0.170 | |
| 每股派息 (元) * | -- | -- | 0.350 | 0.250 | 0.500 | 0.700 | |
| 每股淨資產 (元) * | 12.260 | -2.31% | 12.267 | 14.036 | 14.790 | 20.398 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 18/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
